{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-025807","form_type":"8-K","ticker":"DRIO","cik":"0001533998","company_name":"DarioHealth Corp.","filed_at":"2024-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.529848+00:00","generated_at":"2026-06-05T22:02:15.542927+00:00","sec_items":["1.01","2.03","3.02","5.02","7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"DarioHealth acquires Twill for $10M cash + ~10M pre-funded warrants; raises $22.4M PIPE","bullets":["Acquisition expected to nearly double pro forma 2023 revenue, to ~$30.5M combined.","Gross margins targeted at 80-85% by 2025; cost synergies of ~30% within two years.","Concurrent $22.4M private placement of convertible preferred stock at conversion prices $2.02/$2.14.","Tomer Ben-Kiki, Twill co-founder, appointed COO with $340K salary + stock option for 1,017,947 shares.","Twill brings customers including three of top eight national health plans and multiple Fortune 100 employers."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-025807","json":"https://secwatch.observer/filing/0001104659-24-025807.json","markdown":"https://secwatch.observer/filing/0001104659-24-025807.md","text":"https://secwatch.observer/filing/0001104659-24-025807.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533998/000110465924025807/0001104659-24-025807-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533998/000110465924025807/tm246662d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T22:02:15.542927+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1a8cff8c60","claim":"Tomer Ben-Kiki was appointed as Chief Operating Officer at DarioHealth Corp..","evidence_excerpt":"On February 15, 2024, the Company appointed Tomer Ben-Kiki, age 53, as Chief Operating Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465924025807/0001104659-24-025807-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"1a98ef7ef0aed9147005e24de13815f673c97a4b","claim":"DarioHealth Corp. entered into Agreement and Plan of Merger with Twill, Inc. (effective 2024-02-15).","evidence_excerpt":"(“Merger Sub”), Twill, Inc. (“Twill”) and Bilal Khan, solely in his capacity as the representatives of Twill’s stockholders and other equity holders, entered into an Agreement and Plan of","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465924025807/0001104659-24-025807-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Twill, Inc."},{"label":"Effective","value":"2024-02-15"}],"fact_type":"material_agreement"},{"claim_id":"f22fa815e29d52a4b2b1d9573822c61985b6326e","claim":"DarioHealth Corp. entered into Series C Purchase Agreement with accredited investors valued at approximately $22,422,000 (effective 2024-02-15).","evidence_excerpt":"the Company entered into securities purchase agreements (each, a “Series C Purchase Agreement”) with accredited investors relating to an offering (the “Offering”) and the sale of an aggregate of (i) 17,307 shares of newly designated Series C Preferred Stock","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465924025807/0001104659-24-025807-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"accredited investors"},{"label":"Value","value":"approximately $22,422,000"},{"label":"Effective","value":"2024-02-15"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}